Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Comment by Yajneon Oct 06, 2024 2:16pm

RE:RE:The Real Value Of A Breakthrough Therapy Designation:

Great find Pandora, thanks for posting. Those are all stories that keep 'hope' alive for TLT longs
Comment by DeathXray33on Oct 06, 2024 12:08pm

RE:Certainly the impact of this will add value IMHO

"Of all the microbes on the planet, viruses are the most abundant, with an estimated nonillion (10^30) in the ocean alone. And of course we know viruses can be airborne - that is one of their ...more  
Comment by menoalittleon Oct 06, 2024 10:26am

RE:Certainly the impact of this will add value IMHO

While that is certainly true, I think it probably only scratches the surface of it's potential (and hopefully eventual) application and value in treating metastasis cancer (in the liver, and ...more  
Post by Oden6570on Oct 06, 2024 3:52am

Certainly the impact of this will add value IMHO

Rutherrin® has been designed for intravenous administration and has demonstrated preclinically to be highly effective in a number of established animal models of human cancer, including Non ...more  
Comment by Pandoraon Oct 05, 2024 6:45pm

RE:The Real Value Of A Breakthrough Therapy Designation:

Today's Financial Post features a write up on 5 short term winners for 2024. 4 of them are biopharm and mostly without even having revenue: https://financialpost.com/investing/stocks-short-term ...more  
Comment by toade1313on Oct 05, 2024 5:59pm

RE:RE:RE:The Real Value Of A Breakthrough Therapy Designation:

I have asked both on the Theralase live chat and the info@therslase.com whether shareholders would hear a)when pre-BTD was filed, b) when BTD was filed, or c) when BTD was approved or denied. I have ...more  
Comment by Legit62on Oct 05, 2024 5:04pm

RE:RE:The Real Value Of A Breakthrough Therapy Designation:

If i remember correctly, a board member here said we were still on tract for BTD application in 3rd qtr from an email form TLT, have we heard anything to date to verify this claim??We are into 4th qtr ...more  
Comment by DeathXray33on Oct 05, 2024 4:28pm

RE:RE:RE:266% increase...

You definitely want to have Ruvidar Rutherrin for space travel; humans on planet Mars for example.-------------------- "In previous Theralase research, it was demonstrated that Ruvidar combined ...more  
Comment by Bigkahuna57on Oct 05, 2024 10:27am

RE:The Real Value Of A Breakthrough Therapy Designation:

@O12009, Thank you for bringing this source and information back, so everyone can see for themselves the value of BTD. Here's the link original Seeking Alpha article from 2019.  https ...more  
Post by O12009on Oct 04, 2024 5:37pm

The Real Value Of A Breakthrough Therapy Designation:

Posted Dec 2019 Summary Average approval time reduced by 2.5-3.5 years. Breakthrough therapy designation usually increases valuation significantly. Takeover offers typically ...more  
Post by O12009on Oct 04, 2024 10:35am

Everyone seems to be holding tight

Not a share traded on any Canadian exchange. Yesterday had some people picking up shares. The cross traders must be losing some into the market. More than a few are expecting good news around the ...more  
Comment by DeathXray33on Oct 03, 2024 3:24pm

RE:Bullboard header...

My average went down a penny today so I'm grateful for that. It took a while though.
Comment by Alamir1111on Oct 03, 2024 2:41pm

RE:RE:Time to buy now?

Wait for .17 pp good buy
Post by Jonathon Brownon Oct 03, 2024 9:11am

Buzz on the Bullboards: Stocks to watch as TSX soars amid Mideast tensions

Comment by riverrrowon Oct 02, 2024 4:06pm

RE:Time to buy now?

While I have complete confidence in TLT insiders keeping negotiations secret that doesn't mean potential buyers can do the same.  GLTA.
Comment by Dumbeldorfwhiteon Oct 02, 2024 3:55pm

RE:Time to buy now?

Been "time to buy" for 12 years now. And since the price has steadily declined over those 12 years, it's been "bought too early" according to Bencro for 12 straight years.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250



USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse